Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 9월 10

BrightSpring Health Services Inc

BTSGNASDAQ
Trade with Public
Trade with Public
$61.99
-0.57-0.91%
가까이에: Sep 8, 5:00 PM EST
$61.90
-0.66-1.05%
프리마켓: 7:00 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

BrightSpring Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for BrightSpring Health (BTSG).

Price Target Range — 11 Quarters

Analyst Consensus — 19 Analysts

1S.Buy
17Buy
1Hold
Consensus RatingBuy# Analysts19Avg. Consensus PT$54Upside to Avg. PT-12.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 13, 2026BTIGDavid LarsenMaintainedBuy$90
Aug 3, 2026BTIGDavid LarsenMaintainedBuy$90
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $80

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $71 to $80.
Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on BrightSpring Health, Raises Price Target to $80

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $60 to $80.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $78

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $61 to $78.
Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $81

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $81.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved